期刊文献+

阿戈美拉汀的合成新工艺 被引量:1

The New Technology of Synthesize Agomelatine
下载PDF
导出
摘要 介绍了以7-甲基四氢萘-1-酮和氰乙酸为原料,合成(7-甲氧基-3,4-二氢-1-萘基)乙腈,再芳构化生成(7-甲氧基-1-萘基)乙腈,再还原乙酰化"一锅"反应得到阿戈美拉汀的全过程。全程反应条件温和,总收率约77%。 The text is concerned with a process for the preparation of agomelatine. First the intermediate, namely 2-(7-methoxy-3, 4-dihydronaphthalen-l-yl)acetonitrile, has been prepared by 7-methoxy-3, 4-di- hyctronaphthalen-l(2H)-one and Cyanoacetic acid as raw materials. Further, the intermediate is processed by aromatization to produce 2-(7-methoxynaphthalen-1-yl) acetonitrile. At last, go through reduction and acetylation to get agomelatine.
出处 《四川化工》 CAS 2013年第3期1-3,共3页 Sichuan Chemical Industry
关键词 芳构化 还原乙酰化 阿戈美拉汀 aromatization reduction and acetylation agomelatine
  • 相关文献

参考文献8

  • 1刘英鑫.Servier公司新的抗抑郁剂[J].国外药讯,2002(11):16-17. 被引量:11
  • 2Montgomery S A,Kennedy S H,Burrows G D. Absence of dis- continuation symptoms with agomelatine and occurrence of discontin- uation symptoms with paroxetine: A randomized double-blind,place- bo-controlled discontinuation study[J]. Int Clin Psychopharmacol, 2004, 19: 271-280.
  • 3Loo H,Hale A,D'Haenen H. Determination of the dose of ag- omelatine,a melatoninergic agonist and selective 5-HT(2C) antago- nist,in the treatment of major depressive disorder: A placebo-con- trolled dose range study[J]. Int Clin Psychopharmacol, 2002, 17: 239-247.
  • 4Kennedy S H,Rizvi S, Fulton K, et aI. A double-blind compari- son of sexual functioning, antidepressant e{ficacy, and tolerability between agomelatine and venlafaxine XR[J]. J Clin Psychopharma- eol,2008,28(3) : 29-33.
  • 5Sidney H Kennedy,Sakina J Rizvi. Agomelatine in the treatment o{ maior depressive Disorder[J]. CNS Drugs,2010,24(6) : 481.
  • 6王德才,葛恒平,刘竺云,彭宇然,周国春.阿戈美拉汀的合成方法介绍[J].合成化学,2011,19(3):287-290. 被引量:6
  • 7唐家邓,岑均达.阿戈美拉汀的合成[J].中国医药工业杂志,2008,39(3):161-162. 被引量:18
  • 8WO 2005061457.

二级参考文献17

  • 1景新(摘).阿戈美拉汀对抑郁症有振奋精神的优点[J].国外药讯,2006(5):20-20. 被引量:9
  • 2Montgomery S A, Kennedy S H, Burrows G D. Absence of discontinuation symptoms with agomelatinc and occurrence of discontinuation symptoms with paroxetinc: A randomized, double-bllnd, placebo-controlled discontinuation study [ J ]. Int Clin Psyehopharmaeol, 2004,19:271 -280.
  • 3M B Girish, K Bhuvana, G Nagesh Raju, et al. A novel atypical antidepressant drug: Agomelatine [ J ]. Int J Pharm Biomed Res,2010,1(3) :113 - 116.
  • 4Loo H, Hale A, D' Haenen H. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: A placebo-controlled dose range study [ J ]. Int Clin Psychopharmacol, 2002,17 : 239 - 247.
  • 5Kennedy S H, Rizvi S, Fulton K, et al. A double- blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and yenlafaxine XR [ J ]. J Clin Psychopharmaeol, 2008,28 (3) :29 -33.
  • 6Sidney H Kennedy, Sakina J Rizvi. Agomelatine in the treatment of major depressive Disorder [ J ]. CNS Drugs,2010,24 (6) :481.
  • 7Andrieux. Nouveaux derlves, a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qufles contiennent [ P]. EP 91 400 526.9,1991.
  • 8T·迪比费.合成(7-甲氧基-1-萘基)乙腈的新方法和在合成阿戈美拉汀中的应用[P].CN200880101738.X,2008.
  • 9张鹏.阿戈美拉汀中间体(7-甲氧基-1-萘基)乙酸酯的制备方法[P].CN200910046935.2,2009.
  • 10Souvie Jean-Claude. Nouveau pocede de synthese et nouvelle forme crystalline de I'agomelatinc ainsi que les compositions phannaeeutiques qui la eontienent [P]. EP 05 290 308.5,2005.

共引文献26

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部